New York State Common Retirement Fund’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

New York State Common Retirement Fund’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-804	Closed	-$240	–	3459
2023 Q2	$240	Sell	804 -26,800	-97%	-$8.08K	﹤0.01%	3397
2023 Q1	$11.9K	Buy	27,604 +191	+0.7%	+$147	﹤0.01%	3167
2022 Q4	$32.3K	Buy	27,413 +513	+2%	+$835	﹤0.01%	3136
2022 Q3	$62K	Sell	26,900 -6,300	-19%	-$16.5K	﹤0.01%	3103
2022 Q2	$73K	Buy	+33,200	New	+$230K	﹤0.01%	3173

New York State Common Retirement Fund's GRNA Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 804 shares — an estimated $240 sold.

New York State Common Retirement Fund first reported a position in GRNA in Q2 2022 and held it in 5 quarters. The position peaked at $73K in Q2 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

New York State Common Retirement Fund reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 804 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $240.
New York State Common Retirement Fund first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 5 quarters.
New York State Common Retirement Fund's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $73K in Q2 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.